Module for converting voltage between a high-voltage electrical network of an aircraft and an energy storage element
    1.
    发明授权
    Module for converting voltage between a high-voltage electrical network of an aircraft and an energy storage element 有权
    用于在飞机的高压电力网络和能量存储元件之间转换电压的模块

    公开(公告)号:US09197088B2

    公开(公告)日:2015-11-24

    申请号:US13976215

    申请日:2011-12-22

    摘要: A module converting voltage between a high-voltage electrical network and at least one energy storage element an aircraft, the conversion module configured to reversibly convert between a DC voltage of the high-voltage electrical network and a DC voltage of the energy storage element, the DC voltage of the energy storage element floating relative to the DC voltage of the high-voltage electrical network and centered relative to the mass of the aircraft, the module including an input module including two filters each capable of receiving a DC voltage, a first arm and a second arm including switches, and a mechanism controlling the switches, operating per cycle of a switching period and capable of controlling at least one first switch and at least one second switch identically but offset by a half-period, whereby the first switch is open when the second switch is closed and vice versa.

    摘要翻译: 一种将高压电网和至少一个能量存储元件之间的电压转换成飞行器的模块,所述转换模块被配置为在高压电网的直流电压和能量存储元件的直流电压之间可逆地转换, 能量存储元件的直流电压相对于高压电网的直流电压而相对于飞行器的质量而相对于所述质量浮动,该模块包括一个包括两个能够接收直流电压的滤波器的输入模块,第一臂 以及包括开关的第二臂,以及控制开关的机构,每个开关周期的周期操作,并且能够同时控制至少一个第一开关和至少一个第二开关,但偏移半个周期,由此第一开关是 当第二个开关闭合时打开,反之亦然。

    Canine leishmania vaccine
    2.
    发明授权
    Canine leishmania vaccine 有权
    犬利什曼原虫疫苗

    公开(公告)号:US08871225B2

    公开(公告)日:2014-10-28

    申请号:US12839580

    申请日:2010-07-20

    摘要: The present invention provides vectors that contain and express in vivo Leishmania KMP11 or an epitope thereof that elicits an immune response in a dog against Leishmania, compositions comprising said vectors, methods of vaccination against Leishmania, and kits for use with such methods and compositions.

    摘要翻译: 本发明提供含有体内利什曼原虫KMP11或其表位的载体,其在狗中针对利什曼原虫引起免疫应答,包含所述载体的组合物,针对利什曼原虫接种的方法,以及用于此类方法和组合物的试剂盒。

    Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7
    3.
    发明申请
    Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7 有权
    关节软骨基因治疗与重组载体编码BMP-7

    公开(公告)号:US20090093427A1

    公开(公告)日:2009-04-09

    申请号:US11867919

    申请日:2007-10-05

    IPC分类号: A61K31/70 A61P19/02

    摘要: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of osteoarthritis in mammals, advantageously in humans, dogs, horses and cats, by intra-articular administration of the recombinant vectors and pharmaceutical compositions of the invention.

    摘要翻译: 本发明涉及在宿主细胞中表达BMP-7多肽的重组载体以及包含这种重组载体的药物组合物。 本发明还包括通过关节内施用本发明的重组载体和药物组合物来预防和/或治疗哺乳动物,有利地在人,狗,马和猫中的骨关节炎的方法。

    Canine GHRH gene, polypeptides and methods of use
    4.
    发明授权
    Canine GHRH gene, polypeptides and methods of use 有权
    犬GHRH基因,多肽和使用方法

    公开(公告)号:US07468273B2

    公开(公告)日:2008-12-23

    申请号:US11015461

    申请日:2004-12-17

    IPC分类号: C12N15/63 A61K48/00

    CPC分类号: C07K14/60

    摘要: The present invention relates to a canine pre-proGHRH polypeptide, a canine mature GHRH peptide, an isolated polynucleotide which encodes the canine pre-proGHRH or the canine mature GHRH. The invention also encompasses vectors encoding and expressing the canine pre-proGHRH or the canine GHRH which can be used to treat disease and growth hormone deficiencies by gene therapy in vertebrates, in particular in dogs.

    摘要翻译: 本发明涉及犬pre-proGHRH多肽,犬成熟GHRH肽,编码犬pre-proGHRH或犬成熟GHRH的分离的多核苷酸。 本发明还包括编码和表达犬pre-proGHRH或犬GHRH的载体,其可用于通过脊椎动物,特别是狗中的基因治疗来治疗疾病和生长激素缺乏。

    Inner door for an automotive vehicular door assembly
    6.
    发明授权
    Inner door for an automotive vehicular door assembly 有权
    汽车车门总成内门

    公开(公告)号:US06779829B2

    公开(公告)日:2004-08-24

    申请号:US10342934

    申请日:2003-01-15

    IPC分类号: B62D2504

    CPC分类号: B60J5/0427

    摘要: An automotive door assembly (10) includes an inner door (30) having an inner panel (40). The inner panel (40) has a first seat (44) and a second seat (46) integrally formed therein. The first seat (44) has a first side member (50) fixedly attached thereto for separating an exterior of the door assembly (10) from a door cavity thereof. The first side member (50) also reinforces the automotive door assembly (10). Likewise, the second seat (46) a second side member (90) has fixedly attached thereto for separating the exterior of the door assembly (10) from the door cavity thereof. The second side member (90) also reinforces the automotive door assembly (10). The inner panel (40), the first side member (50), and the second side member (90) have an outer door (18) attached thereto for enclosing the door cavity.

    摘要翻译: 汽车门组件(10)包括具有内板(40)的内门(30)。 内板(40)具有一体地形成在其中的第一座(44)和第二座(46)。 第一座(44)具有固定地附接到其上的第一侧构件(50),用于将门组件(10)的外部与门室隔开。 第一侧构件(50)还加强了汽车门组件(10)。 同样地,第二座(46),第二侧构件(90)固定地附接到其上,用于将门组件(10)的外部与其门腔分离。 第二侧构件(90)还加强了汽车门组件(10)。 内板(40),第一侧构件(50)和第二侧构件(90)具有附接到其上的外门(18)以封闭门腔。

    Preparation of picric acid
    7.
    发明授权
    Preparation of picric acid 失效
    苦味酸的制备

    公开(公告)号:US6063967A

    公开(公告)日:2000-05-16

    申请号:US94595

    申请日:1998-06-15

    CPC分类号: C07C201/16 C07C201/08

    摘要: Picric acid, namely, 2,4,6-trinitrophenol, is readily and effectively prepared by nitrating o-nitrophenol and/or p-nitrophenol into at least one dinitrophenol in a nitric acid medium of reaction, characteristically essentially consisting of nitric acid or immixture thereof with a strong co-acid, the at least one dinitrophenol remaining soluble in the medium of reaction, and therein completing nitration of the at least one dinitrophenol and precipitating picric acid therefrom.

    摘要翻译: 苦味酸,即2,4,6-三硝基苯酚,通过在硝酸反应介质中将邻硝基苯酚和/或对硝基苯酚硝化成至少一种二硝基酚而容易且有效地制备,其特征在于主要由硝酸或杂质组成 其中所述至少一种二硝基苯酚仍然可溶于所述反应介质中,并且其中完成所述至少一种二硝基苯酚的硝化并从其沉淀出苦味酸。

    Preparation of p-nitrophenolic compounds
    8.
    发明授权
    Preparation of p-nitrophenolic compounds 失效
    对硝基酚类化合物的制备

    公开(公告)号:US5414148A

    公开(公告)日:1995-05-09

    申请号:US249200

    申请日:1994-05-26

    CPC分类号: C07C201/00 C07C201/08

    摘要: p-Nitrophenolic compounds, e.g., p-nitrophenol itself, are selectively prepared by (a) reacting a phenolic compound with a nitrosating agent in the presence of sulfuric acid, the concentration of which H.sub.2 SO.sub.4 being at least 60%, (b) oxidizing the p-nitrosophenolic compound thus formed with nitric acid, the concentration of sulfuric acid in the medium of reaction, upon completion of oxidation, being no greater than 80%, and (c) separating the p-nitrophenolic compound which thus precipitates.

    摘要翻译: 通过(a)在硫酸存在下使酚类化合物与亚硝化剂反应,其中H 2 SO 4的浓度为至少60%,(b)将硝基酚类化合物氧化为 由硝酸形成的对亚硝基苯酚化合物,氧化后的反应介质中的硫酸浓度不大于80%,(c)分离因此析出的对硝基酚化合物。

    METHOD FOR ACQUIRING DATA FROM A USER AT THE TIME OF A CARD PAYMENT MADE USING A PAYMENT TERMINAL
    9.
    发明申请
    METHOD FOR ACQUIRING DATA FROM A USER AT THE TIME OF A CARD PAYMENT MADE USING A PAYMENT TERMINAL 有权
    在使用付款终端的卡付款时从用户那里获取数据的方法

    公开(公告)号:US20120116846A1

    公开(公告)日:2012-05-10

    申请号:US13322770

    申请日:2010-06-07

    IPC分类号: G06Q30/02 G06Q40/00

    摘要: The invention relates to a method for acquiring data from a user at the time of a card payment made using a payment terminal, in which: a data acquisition request is displayed (26) on a screen of the payment terminal following the completion of the payment transaction; the data is acquired (28) by the payment terminal; the acquired data is validated (30) in the terminal; and, if the data is valid, the data is transmitted (34 or 37) by the payment terminal to a consolidation server and a card removal authorisation message is displayed (36) on the screen of the terminal. The acquisition includes a maximum period parameter and the data is considered to be invalid if acquired after said maximum period and/or if acquired when the chip card is not in the payment terminal.

    摘要翻译: 本发明涉及一种用于在使用支付终端进行卡支付时从用户获取数据的方法,其中:数据获取请求在付款完成之后在支付终端的屏幕上显示(26) 交易; 数据由支付终端获取(28); 所获取的数据在终端中被验证(30); 并且如果数据有效,则由支付终端向合并服务器发送数据(34或37),并且在终端的屏幕上显示卡删除授权消息(36)。 所述获取包括最大周期参数,并且如果在所述最大周期之后获取,和/或当芯片卡不在支付终端中时获取数据,则认为数据无效。

    Her2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals
    10.
    发明申请
    Her2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals 有权
    Her2 DNA疫苗作为伴侣动物癌症的辅助治疗

    公开(公告)号:US20120093841A1

    公开(公告)日:2012-04-19

    申请号:US13272651

    申请日:2011-10-13

    摘要: The application discloses therapeutic vaccines based upon the “pING” DNA plasmid vector expressing the gene encoding the rat Her2 protein. Vaccines according to the instant disclosure are used as an adjunct treatment for surgery, radiation and/or chemotherapy for dogs and cats with cancers that over express the Her2 antigen, and prolong the post-surgical disease free interval and/or survival time. Also included are therapeutically effective methods of immunization using said vaccines.

    摘要翻译: 该申请公开了基于表达编码大鼠Her2蛋白的基因的“pING”DNA质粒载体的治疗性疫苗。 根据本公开的疫苗被用作用于具有过表达Her2抗原的癌症的狗和猫的手术,放射和/或化学疗法的辅助治疗,并且延长了手术后无疾病间隔和/或存活时间。 还包括使用所述疫苗的治疗有效的免疫方法。